FADS2 and breast carcinoma: Breast tumors and breast cancer cell lines have reduced levels of delta-6 desaturase (FADS2) compared to non-malignant cells [186, 187], as is delta-5 desaturase (FADS1) in non-small-cell lung cancer [188] and esophageal squamous cell carcinoma [189].